Management of Anxiety-Related Headaches
For headaches caused by anxiety, the primary treatment approach should address the underlying anxiety disorder directly, as treating anxiety often improves headache symptoms, while headache-specific medications alone may provide inadequate relief.
Understanding the Clinical Context
The evidence provided focuses predominantly on migraine management rather than anxiety-attributed headaches specifically. However, one recent observational study 1 characterizes headache attributed to anxiety and depressive disorders (HA-ADD) as a distinct entity with specific features: bilateral, dull, moderate-to-severe pain with short attack duration (<4 hours in 60.4% of cases), prominent phonophobia (79.2%), restlessness (58.4%), and triggers including emotional fluctuations (71.3%) and poor sleep (57.4%).
Treatment Algorithm
Step 1: Confirm the Diagnosis
- Verify this is truly anxiety-attributed headache, not migraine with comorbid anxiety (a critical distinction)
- Look for: bilateral dull pain, temporal/parietal location, phonophobia, restlessness, emotional triggers
- Rule out primary headache disorders that may coexist with anxiety 2
Step 2: Prioritize Anxiety Treatment
The underlying anxiety disorder must be the primary treatment target 3. The evidence consistently shows that treating comorbid psychiatric conditions improves headache outcomes when implemented within a comprehensive program 3.
Pharmacologic Options for Anxiety:
Dual-action agents that treat both anxiety and headache prophylaxis:
Anxiety-specific medications (when headache prophylaxis not needed):
Step 3: Acute Headache Management (When Needed)
For breakthrough headache episodes:
- NSAIDs (ibuprofen 400-800mg, naproxen 275-550mg) 7
- Acetaminophen in combination with NSAIDs or aspirin plus caffeine 7
- Avoid: Opioids and butalbital-containing compounds 8 - these risk dependency and medication overuse headache
Step 4: Non-Pharmacologic Interventions
These are essential components, not optional add-ons:
- Behavioral treatments: relaxation training, biofeedback, cognitive-behavioral therapy (first-line evidence-based options) 9
- Stress management with relaxation techniques or mindfulness practices 8
- Lifestyle modifications: consistent sleep schedule, regular meals, hydration, regular aerobic exercise 8, 4
- Physical therapy or structured aerobic exercise 4
Critical Pitfalls to Avoid
Do not treat as migraine without confirming diagnosis - The provided guidelines 8 address migraine specifically, which has different pathophysiology than anxiety-attributed headache
Do not use triptans - These are migraine-specific medications and inappropriate for anxiety-attributed headache
Monitor for medication overuse headache - Limit acute treatments to <2 days per week 10; threshold is ≥15 days/month for NSAIDs, ≥10 days/month for triptans 8
Address stigma proactively - Patients may resist psychiatric diagnosis or treatment; education about the mind-body connection and expected benefits is essential 3
Do not assume headache improvement equals anxiety improvement - Recent evidence shows CGRP agents improved headaches but not psychiatric symptoms in comorbid cases, emphasizing the need for parallel mental health intervention 2
When to Refer
Consider neurology or headache specialist referral if:
- Diagnostic uncertainty between anxiety-attributed headache and primary headache disorder
- Inadequate response to first-line anxiety treatment after 8-12 weeks
- Frequent headaches (≥15 days/month) suggesting possible chronic migraine
- Red flags for secondary headache (new onset in older patient, progressive worsening, neurologic symptoms) 7
The key principle: anxiety-attributed headaches require treating the anxiety disorder as the primary intervention, with acute headache medications serving only as adjunctive symptomatic relief.